Mumps
📧 Sign up to get email alerts when something new happens for Mumps.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-03-27Clinical Trial Update: Special Drug Use Investigation for Botox® (Botulinum) Spasticity (BOTOX is a Registered Trademark of Allergan, Inc.)
This document records a completed Special Drug Use Investigation involving Botox (onabotulinumtoxinA) for spasticity, with the listed condit…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Making Decisions About the Measles-Mumps-Rubella Vaccine [NA]
This clinical trial update discusses decisions about the Measles-Mumps-Rubella vaccine (MMR). The University of Michigan–sponsored study is …
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of Japanese Encephalitis Chimeric Virus Vaccine Given With Measles-Mumps-Rubella Vaccine in Taiwanese Toddlers [Phase 3]
A Phase 3 trial in Taiwanese toddlers evaluated co-administration of a Japanese Encephalitis chimeric virus vaccine with a Measles-Mumps-Rub…
-
CLINICAL_TRIALS trial_result · 2014-07-02Clinical Trial Update: Safety, Tolerability, and Immunogenicity of Measles, Mumps, Rubella, and Varicella (MMRV) Vaccine Made With an Alternative Manufacturing Process (AMP)(V221-027) [Phase 3]
Phase 3 trial evaluating safety, tolerability, and immunogenicity of an alternative manufacturing process for MMRV vaccine (AMP) with comple…
-
CLINICAL_TRIALS trial_result · 2014-01-22Clinical Trial Update: Immunogenicity and Safety of Hepatitis A Vaccine Given at the Same Time of Measles, Mumps, Rubella Combined Vaccine [Phase 4]
Phase 4 trial evaluating immunogenicity and safety when a Hepatitis A vaccine is given at the same time as the Measles, Mumps, and Rubella v…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
Completed serology study in children aged 12 to 23 months who received the Measles, Mumps, and Rubella (MMR) vaccine. Sponsored by Bio-Mangu…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants [Phase 2, Phase 3]
This clinical trial update reports on the immunogenicity and reactogenicity of the trivalent measles-mumps-rubella vaccine Trivivac in healt…
-
CLINICAL_TRIALS trial_result · 2012-10-10Clinical Trial Update: A Study of ProQuad™ in Healthy Children in Korea (V221-023) [Phase 3]
Phase 3 trial of ProQuad in healthy children in Korea was terminated; results were posted in 2012.
-
CLINICAL_TRIALS trial_result · 2011-11-04Clinical Trial Update: Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age [Phase 2]
Phase 2 trial evaluating the immunogenicity of GSK's MMR vaccine (209762) compared with M-M-R II when co-administered with routine vaccines …
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Study of the Safety of Menactra® Vaccine When Administered With Other Pediatric Vaccines to Healthy Toddlers [Phase 3]
A Phase 3 safety study evaluating the co-administration of Menactra meningococcal vaccine with other pediatric vaccines in healthy toddlers;…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Immunogenicity and Safety of Pediatric Vaccines When Administered With Menactra® in Healthy Toddlers [Phase 3]
This Phase 3 trial evaluated the immunogenicity and safety of pediatric vaccines administered with Menactra in healthy toddlers, with result…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers [Phase 3]
A Phase 3 study evaluated two doses of Menactra meningococcal conjugate vaccine in healthy toddlers. The trial is completed and results were…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Immune Responses to Two Dose Varivax +/- MMR-II [Phase 1, Phase 2]
A Phase 1/2 clinical trial assessing immune responses to two doses of Varivax with or without MMR-II in measles, mumps, rubella, and varicel…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
The trial update describes immune responses of premature infants to the Measles-Mumps-Rubella (MMR) and Varicella vaccines, with the study s…
-
CLINICAL_TRIALS trial_result · 2010-08-26Clinical Trial Update: Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age [Phase 2]
Phase 2 trial comparing MMRV vaccine from GlaxoSmithKline to ProQuad in children 12-14 months, assessing immunogenicity and safety for varic…
-
CLINICAL_TRIALS trial_result · 2010-02-25Clinical Trial Update: Frozen ProQuad Administered Concomitantly Versus Nonconcomitantly With Other Pediatric Vaccines [Phase 3]
A Phase 3 study evaluated administering Frozen ProQuad concurrently with other pediatric vaccines versus separately, with results posted Feb…
-
CLINICAL_TRIALS trial_result · 2010-02-15Clinical Trial Update: ProQuad Dose Selection Study (V221-011)(COMPLETED) [Phase 2]
A Phase 2 dose-selection study of ProQuad evaluated different dosing regimens to determine the optimal dose for protection against measles, …
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: ProQuad™ Versus M-M-R II™ and VARIVAX™ in Healthy Children (V221-009)(COMPLETED) [Phase 3]
Phase 3 trial comparing ProQuad (MMRV) with separate M-M-R II (MMR) and VARIVAX (varicella) vaccines in healthy children; the study is compl…
-
CLINICAL_TRIALS trial_result · 2010-02-10Clinical Trial Update: V221 Concomitant Use Study With Pneumococcal Conjugate Vaccine (V221-019) [Phase 3]
Phase 3 clinical trial update reporting results for V221-019, a concomitant-use study with Pneumococcal Conjugate Vaccine sponsored by Merck…
-
CLINICAL_TRIALS trial_result · 2010-02-09Clinical Trial Update: Safety, Tolerability, and Immunogenicity of 3 Frozen ProQuad Consistency Lots in Healthy Children (V221-012)(COMPLETED) [Phase 3]
This Phase 3 clinical trial evaluated safety, tolerability, and immunogenicity across three frozen ProQuad lot consistency lots in healthy c…
-
CLINICAL_TRIALS trial_result · 2010-01-29Clinical Trial Update: A Study of ProQuad in Healthy 4 to 6 Year Old Children (V221-014) [Phase 3]
Phase 3 trial of ProQuad in healthy children completed; results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2009-07-03Clinical Trial Update: Seroimmunity 2007 and Sub Study of the Swedish Population Regarding Vaccine Preventable Disease
Clinical trial update on Seroimmunity 2007 and a sub-study of the Swedish population assessing seroprevalence for vaccine-preventable diseas…
-
CLINICAL_TRIALS trial_result · 2008-11-20Clinical Trial Update: Hepatitis A Vaccine, Inactivated and Measles, Mumps, Rubella and Varicella Virus Vaccine Live Safety Study (V251-066)(COMPLETED) [Phase 4]
A Phase 4 safety study evaluating Merck's Hepatitis A inactivated vaccine and Measles, Mumps, Rubella and Varicella Live vaccine (ProQuad) h…
-
CLINICAL_TRIALS trial_result · 2008-10-13Clinical Trial Update: Immunogenicity/Safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA): Using Two Different Administration Routes [Phase 3]
Phase 3 trial evaluating immunogenicity and safety of Measles-Mumps-Rubella-Varicella Vaccine (MeMuRu-OKA) using two administration routes; …
-
CLINICAL_TRIALS trial_result · 2008-02-08Clinical Trial Update: Trial to Assess Safety, Tolerability, and Immunogenicity of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold-Adapted (FluMist) and Measles, Mumps, Rubella, and Varicella Vaccines Administered Concurrently to Healthy Children [Phase 3]
A Phase 3 trial evaluated safety, tolerability, and immunogenicity when FluMist and MMRV vaccines were administered concurrently to healthy …